Plasticity of the cell state has been proposed to drive resistance to multiple classes of cancer therapies, thereby limiting their effectiveness1–4. A high-mesenchymal cell state observed in human tumours and cancer cell lines has been associated with resistance to multiple treatment modalities across diverse cancer lineages, but the mechanistic underpinning for this state has remained incompletely understood1–6. Here we molecularly characterize this therapy-resistant high-mesenchymal cell state in human cancer cell lines and organoids and show that it depends on a druggable lipid-peroxidase pathway that protects against ferroptosis, a nonapoptotic form of cell death induced by the build-up of toxic lipid peroxides7,8. We show that this cell state is characterized by activity of enzymes that promote the synthesis of polyunsaturated lipids. These lipids are the substrates for lipid peroxidation by lipoxygenase enzymes8,9. This lipid metabolism creates a dependency on pathways converging on the phospholipid glutathione peroxidase (GPX4), a selenocysteine-containing enzyme that dissipates lipid peroxides and thereby prevents the iron-mediated reactions of peroxides that induce ferroptotic cell death8. Dependency on GPX4 was found to exist across diverse therapy-resistant states characterized by high expression of ZEB1, including epithelial-mesenchymal transition in epithelial-derived carcinomas, TGFβ-mediated therapy- resistance in melanoma, treatment-induced neuroendocrine transdifferentiation in prostate cancer, and sarcomas, which are fixed in a mesenchymal state owing to their cells of origin. We identify vulnerability to ferroptic cell death induced by inhibition of a lipid peroxidase pathway as a feature of therapy-resistant cancer cells across diverse mesenchymal cell-state contexts.
A ligand-modified, economical version of Stryker's reagent (SR) has been developed based on a bidentate, achiral bis-phosphine. Generated in situ, "(BDP)CuH" smoothly effects conjugate reductions of a variety of unsaturated substrates, including those that are normally unreactive toward SR. Substrate-to-ligand ratios typically on the order of 1000-10000:1 can be used leading to products in high yields.
Stuck on an sp2 carbon: A new route to geometrically defined α‐alkoxycarbonyl‐substituted vinylboronates consists of the chemo‐ and stereoselective 1,2‐addition of copper hydride to acetylenic esters followed by stereoretentive transmetalation with pinacolborane. This strategy is applied to the generation of an aryl acrylate intermediate in the synthesis of the antiinflammatory drug naproxen (see scheme).
The first study describing a general technology for arriving at valued nonracemic allylic alcohols using asymmetric ligand-accelerated catalysis by copper hydride is described.
Organic chemists
are able to synthesize molecules in greater number
and chemical complexity than ever before. Yet, a majority of these
compounds go untested in biological systems, and those that do are
often tested long after the chemist can incorporate the results into
synthetic planning. We propose the use of high-dimensional “multiplex”
assays, which are capable of measuring thousands of cellular features
in one experiment, to annotate rapidly and inexpensively the biological
activities of newly synthesized compounds. This readily accessible
and inexpensive “real-time” profiling method can be
used in a prospective manner to facilitate, for example, the efficient
construction of performance-diverse small-molecule libraries that
are enriched in bioactives. Here, we demonstrate this concept by synthesizing
ten triads of constitutionally isomeric compounds via complexity-generating
photochemical and thermal rearrangements and measuring compound-induced
changes in cellular morphology via an imaging-based “cell painting”
assay. Our results indicate that real-time biological annotation can
inform optimization efforts and library syntheses by illuminating
trends relating to biological activity that would be difficult to
predict if only chemical structure were considered. We anticipate
that probe and drug discovery will benefit from the use of optimization
efforts and libraries that implement this approach.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.